ONTO · XBRL financial data
Onto Innovation financial statements, every quarter
The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal quarters (ONTO's year ends in early January)
| In millions of dollars | Sep 30, 2023 | Dec 30, 2023 | Mar 30, 2024 | Jun 29, 2024 | Sep 28, 2024 | Dec 28, 2024 | Mar 29, 2025 | Jun 28, 2025 | Sep 27, 2025 | Jan 3, 2026 | Mar 31, 2026 | Jun 30, 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 229 | 242 | 252 | — | 267 | 254 | 218 | — | 292 | 343 |
| Revenue from contracts with customers | 207 | 219* | 229 | 242 | 252 | 264* | 267 | 254 | 218 | 267* | 292 | 343 |
| Cost of revenue | 100 | 111* | 111 | 114 | 116 | 132* | 123 | 131 | 108 | 143* | 146 | 160 |
| Gross profit | 107 | 108* | 118 | 128 | 136 | 132* | 143 | 122 | 111 | 124* | 146 | 183 |
| Research and development | 26 | 24* | 27 | 27 | 28 | 35* | 28 | 35 | 32 | 36* | 35 | 39 |
| General and administrative | 18 | 27* | 18 | 20 | 22 | 26* | 24 | 25 | 25 | 34* | 31 | 34 |
| Total operating expenses | 73 | 80* | 76 | 79 | 83 | 90* | 80 | 90 | 87 | 110* | 113 | 120 |
| Operating income (loss) | 34 | 28* | 43 | 49 | 53 | 42* | 63 | 32 | 24 | 14* | 34 | 64 |
| Other income (expense) | (1) | (1)* | 1 | (0) | (1) | (0)* | (1) | (1) | (1) | (2)* | 5 | 5 |
| Income tax expense (benefit) | 3 | 4* | 4 | 4 | 8 | 2* | 8 | 6 | 4 | 9* | 4 | 8 |
| Net income (loss) | 36 | 30* | 47 | 53 | 53 | 49* | 64 | 34 | 28 | 11* | 34 | 60 |
| Earnings per share, basic USD per share | 0.73 | — | 0.95 | 1.07 | 1.07 | 0.99* | 1.30 | 0.69 | 0.58 | 0.21* | 0.68 | 1.22 |
| Earnings per share, diluted USD per share | 0.73 | 0.61* | 0.94 | 1.07 | 1.07 | 0.98* | 1.30 | 0.69 | 0.57 | 0.21* | 0.67 | 1.21 |
| Weighted average shares, basic millions of shares | 49 | — | 49 | 49 | 49 | 49* | 49 | 49 | 49 | 49* | 50 | 49 |
| Weighted average shares, diluted millions of shares | 49 | 49* | 50 | 50 | 50 | 50* | 49 | 49 | 49 | 50* | 50 | 50 |
Balance sheet
CSVFiscal quarters (ONTO's year ends in early January)
Cash flows
CSVFiscal quarters (ONTO's year ends in early January)
| In millions of dollars | Sep 30, 2023 | Dec 30, 2023 | Mar 30, 2024 | Jun 29, 2024 | Sep 28, 2024 | Dec 28, 2024 | Mar 29, 2025 | Jun 28, 2025 | Sep 27, 2025 | Jan 3, 2026 | Mar 31, 2026 | Jun 30, 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (loss) | 36 | 30* | 47 | 53 | 53 | 49* | 64 | 34 | 28 | 11* | 34 | 60 |
| Stock-based compensation | 6* | 6* | 6 | 8* | 7* | 7* | 7 | 7* | 7* | 7* | 7 | 10* |
| Net cash from operating activities | 29* | 62* | 57 | 65* | 67* | 56* | 92 | 58* | 83* | 95* | 26 | 62* |
| Purchases of property and equipment | 8* | 2* | 7 | 12* | 8* | 5* | 8 | 14* | 1* | 5* | 4 | 4* |
| Net cash from investing activities | (43)* | (37)* | (92) | (74)* | (57)* | (4)* | (22) | (43)* | 297* | (353)* | (113) | (230)* |
| Share repurchases | 0* | 0* | 0 | 0* | 0* | 25* | 75 | 0* | 0* | 0* | 0 | 205* |
| Net cash from financing activities | (1)* | (0)* | (5) | (9)* | 4* | (26)* | (80) | (4)* | 5* | 3* | (7) | 1,170* |
| Net change in cash | (18)* | 27* | (43) | (18)* | 16* | 24* | (9) | 14* | 386* | (257)* | (94) | 1,001* |
Compare with peers
SIC 3829 and related industry codes, similar size. Each row is the latest quarter reported.
How peers are chosen
- SIC 3829 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
- Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
- * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
| Company | Cash ($M) | Revenue, quarter ($M) | Operating cash flow, quarter ($M) | Shares outstanding | Quarter |
|---|---|---|---|---|---|
| Onto Innovation | 1,253 | 343 | 62* | 49.1M | 10-QJun 30, 2026 |
| Cognex | 303 | 291 | 69* | 168.2M | 10-QJul 5, 2026 |
| Mirion Technologies | 409 | 278 | 59* | not reported | 10-QSep 30, 2026 |
| Badger Meter | 68 | 236 | 43* | 28.6M | 10-QSep 30, 2026 |
| Ralliant | 271 | 568 | 106* | 110.6M | 10-QJul 3, 2026 |
| Itron | 840 | 599 | 102* | 43.9M | 10-QSep 30, 2026 |
| Bio-Rad Laboratories | 517 | 651 | 99* | not reported | 10-QJun 30, 2026 |
| Cohu | 272 | 173 | 5.6* | 47.3M | 10-QSep 26, 2026 |
| Revvity | 1,023 | 730 | 192* | 111.6M | 10-QJul 5, 2026 |
Not investment advice. Not affiliated with the U.S. SEC.